Cancer drug tested in pet dogs is now bound for human trials
Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising ...
Jul 17, 2013
0
0